PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Phenytoin
Presentation Product Chemical substance Chapter Items dispensed
Phenytoin 30mg/5ml oral suspension
0408010Z0AAAAAA
Phenytoin Phenytoin Central Nervous System 3,671
Epanutin 30mg/5ml oral suspension
0408010Z0BBAAAA
Epanutin (Suspension/Tablet) Phenytoin Central Nervous System 757
Phenytoin 50mg chewable tablets
0408010Z0AAACAC
Phenytoin Phenytoin Central Nervous System 369
Epanutin Infatabs 50mg chewable tablets
0408010Z0BBABAC
Epanutin (Suspension/Tablet) Phenytoin Central Nervous System 201
Phenytoin 90mg/5ml oral suspension
0408010Z0AAALAL
Phenytoin Phenytoin Central Nervous System 148
Dilantin Infatabs 50mg chewable tablets
0408010Z0BCAAAC
Dilantin Phenytoin Central Nervous System 21
Phenytoin 90mg/5ml oral solution
0408010Z0AABIBI
Phenytoin Phenytoin Central Nervous System 13
Dilantin-30 suspension
0408010Z0BCABAA
Dilantin Phenytoin Central Nervous System No data available
Phenytoin 300mg/5ml oral liquid
0408010Z0AABHBH
Phenytoin Phenytoin Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.